Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    20138607 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Conditions: Keratoconus;   Ectasia;   Corneal Ectasia
Interventions: Device: UV-X Light;   Drug: Riboflavin
2 Unknown  Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia
Condition: Corneal Ectasia
Interventions: Procedure: riboflavin-induced collagen cross-linking treatment;   Device: Riboflavin-UVA induced collagen cross-linking treatment for corneal ectasia

Indicates status has not been verified in more than two years